Added Value of Ultrasonography in the Diagnosis, Management, and Follow-Up of Carpal Tunnel Syndrome
Launched by KAFRELSHEIKH UNIVERSITY · Feb 13, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how ultrasound (a type of imaging) can help diagnose, manage, and monitor carpal tunnel syndrome (CTS), a condition that causes pain and numbness in the hands due to pressure on a nerve in the wrist. The study will compare the use of ultrasound to traditional nerve conduction studies, which measure how well nerves send signals. By using both methods, researchers hope to improve the way doctors diagnose and treat CTS.
To participate in the trial, individuals need to be at least 18 years old and diagnosed with carpal tunnel syndrome. However, those who have had previous wrist surgery, certain medical conditions, or other nerve issues that could confuse the diagnosis won’t be included. If you join the trial, you can expect to have both ultrasound and nerve tests done, and the results may help guide your treatment and follow-up care. This study is currently recruiting participants of all genders, aged 18 and older, who have CTS.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years old.
- • Both sexes.
- • Patients with carpal tunnel syndrome.
- Exclusion Criteria:
- • History of wrist surgery (including carpal tunnel injection) or fracture.
- • Clinical or electrophysiological evidence of an accompanying condition that mimics carpal tunnel syndrome or interferes with its evaluation, such as proximal median neuropathy, cervical radiculopathy or polyneuropathy.
- • History of underlying disorders associated with carpal tunnel syndrome such as diabetes mellitus, rheumatoid arthritis, pregnancy, acromegaly or hypothyroidism.
- • Electrodiagnostic findings suggestive of co-existing neurological disorders.
- • Subclinical sensory polyneuropathy.
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, Kafrelsheikh, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported